Pages that link to "Q51571729"
Jump to navigation
Jump to search
The following pages link to mTOR promotes pituitary tumor development through activation of PTTG1. (Q51571729):
Displaying 9 items.
- TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis (Q41144441) (← links)
- Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours (Q58611476) (← links)
- Histone deacetylase inhibitors suppress transdifferentiation of gonadotrophs to prolactin cells and proliferation of prolactin cells induced by diethylstilbestrol in male mouse pituitary (Q90236072) (← links)
- Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting (Q90679554) (← links)
- mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis (Q91559647) (← links)
- Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study (Q91813329) (← links)
- PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc (Q92442343) (← links)
- The Treatment of Refractory Pituitary Adenomas (Q92699881) (← links)
- Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance (Q96304826) (← links)